Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antineoplastic Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.
Solve capecitabine production challenges with non-toxic alkoxycarbonylation. Avoid phosgene, reduce EHS risks, and achieve >80% yields for stable supply chains.